Metraipolis › archive › dc_ec2caa8198a4

Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience — Europe PMC PMID:42453165

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42453165
DOI
10.3332/ecancer.2026.2150
License (as archived)
solo-consultazione
Archived
2026-10-31T09:44:13.771Z
SHA-256 of the archived text
b97d55673225432b3bd599957205d7f8ffac4a68ca367c888a8e9c95b983dcea
Stable URL of this page
https://metraipolis.com/documento/dc_ec2caa8198a4

How to cite

Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience — Europe PMC PMID:42453165 — Europe PMC (en), https://europepmc.org/article/MED/42453165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec2caa8198a4 (Metraipolis archive dc_ec2caa8198a4, sha256 b97d55673225432b3bd599957205d7f8ffac4a68ca367c888a8e9c95b983dcea)
BibTeX
@misc{dcec2caa8198a4,
  title = {Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience — Europe PMC PMID:42453165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42453165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec2caa8198a4; sha256 b97d55673225432b3bd599957205d7f8ffac4a68ca367c888a8e9c95b983dcea},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42453165. Agents can read the archived copy with the MCP tool read_document.